Suffer from Psoriasis?
If so, you may qualify to participate in a research study

.Receive the FDA-approved medication etanercept (Enbrel)
.10 study visits over 24 weeks
.Must have 10% or more of body surface covered with psoriasis AND be overweight
.Compensation up to $1,000

Please contact us: (617) 726-5066 or harvardskinstudies@partners.org

Institution  –  MGH - Massachusetts General Hospital, Boston, MA

Principal Investigator  – Alexa Kimball, MD

  

For further information about enrolling a patient in this trial, contact the person below.

Name  – Lynne H

Phone  – 617-726-5066